Zobrazeno 1 - 10
of 161
pro vyhledávání: '"F. I. Carroll"'
Autor:
M D Raleigh, S J Peterson, M Laudenbach, F Baruffaldi, F I Carroll, S D Comer, H A Navarro, T L Langston, S P Runyon, S Winston, M Pravetoni, P R Pentel
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0184876 (2017)
Among vaccines aimed at treating substance use disorders, those targeting opioids present several unique medication development challenges. 1) Opioid overdose is a common complication of abuse, so it is desirable for an opioid vaccine to block the to
Externí odkaz:
https://doaj.org/article/3b2e7ab5a7434204b22b8fab42f5d495
Autor:
Olivier George, Robert E. Vann, Louis S. Harris, Jenny L. Wiley, F. I. Carroll, Marc R. Azar, D.M. Walentiny, M. I. Damaj, George F. Koob, K.M. Tobey
Publikováno v:
Psychopharmacology. 223:159-168
Alleviating addiction to tobacco products could prevent millions of deaths. Investigating novel compounds selectively targeting α4β2 nAChRs hypothesized to have a key role in the rewarding effects of nicotine may be a useful approach for future tre
Publikováno v:
British Journal of Pharmacology. 156:1044-1053
Background and purpose Adenylyl cyclase sensitization occurs on chronic agonist activation of mu-opioid receptors and is manifested by an increase in cAMP levels (overshoot) on challenge with antagonist. It has been proposed that a long lasting const
Autor:
Josephine Lee, Rachel J. Donahue, D Foti, Courtney Beard, Daniel G. Dillon, A. Van't Veer, Kean J. Hsu, F I Carroll, Thröstur Björgvinsson, Diego A. Pizzagalli, Elyssa M. Barrick, Chelsea J Webber, William A. Carlezon
Publikováno v:
Translational Psychiatry
Depression has been associated with poor performance following errors, but the clinical implications, response to treatment and neurobiological mechanisms of this post-error behavioral adjustment abnormality remain unclear. To fill this gap in knowle
Autor:
Anna M.W. Taylor, Christopher J. Evans, Kabirullah Lutfy, F. I. Carroll, Amynah A. Pradhan, Kristofer W. Roberts, Wendy Walwyn, Catherine M. Cahill, H A Akbari
Publikováno v:
Taylor, AMW; Roberts, KW; Pradhan, AA; Akbari, HA; Walwyn, W; Lutfy, K; et al.(2015). Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist. British Journal of Pharmacology, 172(2), 691-703. doi: 10.1111/bph.12810. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/0t14s65k
British journal of pharmacology, vol 172, iss 2
British Journal of Pharmacology, vol 172, iss 2
British Journal of Pharmacology
Taylor, AMW; Roberts, KW; Pradhan, AAA; Akbari, HA; Walwyn, WM; Lutfy, K; et al.(2014). Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist. British Journal of Pharmacology. doi: 10.1111/bph.12810. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/1qq8412x
British journal of pharmacology, vol 172, iss 2
British Journal of Pharmacology, vol 172, iss 2
British Journal of Pharmacology
Taylor, AMW; Roberts, KW; Pradhan, AAA; Akbari, HA; Walwyn, WM; Lutfy, K; et al.(2014). Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist. British Journal of Pharmacology. doi: 10.1111/bph.12810. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/1qq8412x
Background and Purpose The opioid receptor family comprises four structurally homologous but functionally distinct sub-groups, the μ (MOP), δ (DOP), κ (KOP) and nociceptin (NOP) receptors. As most opioid agonists are selective but not specific, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994ae2fb64d5c8b5dca7c50718a759e6
http://www.escholarship.org/uc/item/0t14s65k
http://www.escholarship.org/uc/item/0t14s65k
Autor:
Jim A. Thomas, Robert N. Atkinson, D. M. Zimmerman, Noelle Vinson, Richard B. Rothman, Christina M. Dersch, Kenneth M. Gigstad, Nivedita Namdev, Scott E. Fix, Jason P. Burgess, Heng Xu, F. I. Carroll, S. W. Mascarella, B. E. Cantrell
Publikováno v:
Journal of Medicinal Chemistry. 45:3524-3530
A library of compounds biased toward opioid receptor antagonist activity was prepared by incorporating N-phenylpropyl-4beta-methyl-5-(3-hydroxyphenyl)morphans as the core scaffold using simultaneous solution phase synthetic methodology. From this lib
Publikováno v:
Psychopharmacology. 232(15)
Preclinical studies with bupropion in rodent models of nicotine dependence have generated equivocal findings with regard to translating the clinical efficacy of the antidepressant as a smoking cessation agent.Given that rats are poor metabolizers of
Publikováno v:
Behavioural Brain Research. 99:201-208
Chronic continuous cocaine treatment produces a unique pattern of locomotor activation over time. An initial, progressive increase in locomotion is indicative of sensitization. Unlike intermittent cocaine, this increase is subsequently reversed durin
Publikováno v:
Current Medicinal Chemistry. 4:247-270
Ohmefentanyl., or β-hydroxy-3-methylfentanyl, is an unique member of the 4-anilidopiperidine class of opiates. This review summarizes both the initial studies on mixtures of ohmefentanyl stereoisomers and some more recent studies on the eight indivi
Publikováno v:
Neuropharmacology. 35:423-431
Ibogaine is an hallucinogenic indole alkaloid claimed to have anti-addictive properties. Although its mechanism of action is unknown, binding studies have indicated that the drug may interact with N-methyl-D-aspartate (NMDA) receptors. We further inv